FDA RFO2- Cagayan Valley

19/08/2026

****ANNOUNCEMENT || NEW SCHEDULE OF PIC/S GMP TRAINING****

The Training on the PIC/S-GMP Guide PE 009-17 (Version 17) for Drug Manufacturers: Understanding Current Regulatory Requirements and Compliance originally scheduled on 19–20 August 2026 at Vivere Hotel, Muntinlupa City was postponed due to the inclement weather affecting Metro Manila and pursuant to Memorandum Circular No. 129 issued by the office of the President.

Please be informed that the training will now be conducted on 27–28 August 2026 at the same hotel.

All participants are requested to take note of the new schedule. Your cooperation and continued commitment to the program are highly appreciated.

10/08/2026

Online Man o Hindi, Bawal ang Ilegal na Bentahan ng Gamot

✅ Bumili lamang sa lisensyadong botika o awtorisadong online pharmacy.
✅ Suriin ang pinagmulan ng gamot bago bumili.
✅ Huwag tumangkilik sa ilegal na bentahan ng gamot.
✅ Iulat sa pinakamalapit na himpilan ng pulisya o tumawag sa 911.

04/08/2026

Announcement ‼️

Please be informed that our official mobile number is:

+63 927 824 7490

For official inquiries, requests, and communications, kindly use this number.

We encourage everyone to update their records accordingly.

Thank you.

24/07/2026

24/07/2026

𝐁𝐔𝐈𝐋𝐃𝐈𝐍𝐆 𝐀 𝐅𝐔𝐓𝐔𝐑𝐄-𝐑𝐄𝐀𝐃𝐘 𝐀𝐆𝐄𝐍𝐂𝐘: 𝐅𝐃𝐀 𝐈𝐍𝐓𝐑𝐎𝐃𝐔𝐂𝐄𝐒 𝐈𝐓𝐒 𝐒𝐓𝐑𝐀𝐓𝐄𝐆𝐈𝐂 𝐑𝐎𝐀𝐃𝐌𝐀𝐏 𝐅𝐎𝐑 𝟐𝟎𝟐𝟔-𝟐𝟎𝟑𝟎

Anchored on the mandate of Republic Act No. 9711 and aligned with the Philippine Development Plan 2023-2028 and the Department of Health’s 8-Point Action Agenda, the Food and Drug Administration (FDA) has developed its first Five-Year Development Plan for 2026-2030 that will guide the Agency's priorities, programs, and initiatives over the next five years.

The FDA presents its Five-Year Development Plan, the Agency's strategic roadmap for strengthening regulatory systems, improving operational efficiency, and enhancing public service delivery. It also demonstrates the FDA's commitment to transparency by clearly communicating its priorities and long-term direction to stakeholders and the public.

From 2026 to 2030, the Agency will focus more on modernizing regulatory systems, reducing application backlogs, strengthening post-market surveillance, institutionalizing risk-based and reliance approaches, and enhancing stakeholder engagement. The Plan reflects the Agency's shared vision and collective commitment to building a more efficient, transparent, and responsive FDA through the collaboration of its officials, personnel, and partners.

As the FDA responds to evolving public health needs and an increasingly dynamic regulatory environment, this plan reaffirms the Agency’s commitment to protecting and promoting the health of the people by building a more efficient, innovative, and future-ready regulatory agency.

𝘍𝘰𝘳 𝘮𝘰𝘳𝘦 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯, 𝘴𝘦𝘦 𝘵𝘩𝘦 𝘭𝘪𝘯𝘬 𝘪𝘯 𝘵𝘩𝘦 𝘤𝘰𝘮𝘮𝘦𝘯𝘵𝘴.

22/07/2026

𝙆𝙖-𝙩𝙧𝙖𝙙𝙚, 𝙞𝙩’𝙨 𝙩𝙞𝙢𝙚 𝙩𝙤 𝙘𝙚𝙡𝙚𝙗𝙧𝙖𝙩𝙚 𝙗𝙞𝙜!
A new wave of colors, stories, and proudly Cagayan Valley-made products is once again ready to take the spotlight as we bring you the 20th Padday na Lima Regional Trade Fair!

For two decades, this much-loved showcase has been a vibrant meeting place of tradition and innovation. And this year feels even more meaningful as we honor not only the journey of our MSMEs, but also the growing movement toward a more sustainable future, one that keeps our culture alive and thriving for the next generation.

With the theme “20 Years of Vibrant Hands: Crafting a Sustainable Legacy of Culture and Community,” this milestone celebration highlights the creativity, resilience, and craftsmanship of MSMEs from the provinces of Batanes, Cagayan, Isabela, Nueva Vizcaya, and Quirino.

📅 24–30 August 2026
📍 Upper Ground Floor and East Hall, Carousel Court, Festival Mall, Alabang, Muntinlupa City (24–27 August 2026)
📍 Civic Hall, Festival Mall, Alabang, Muntinlupa City (28–30 August 2026)

From woven heritage pieces to flavorful local delicacies and innovative MSME creations, experience a celebration that is rich in culture, strong in community, and rooted in sustainability.
𝘍𝘰𝘭𝘭𝘰𝘸 𝘵𝘩𝘦 𝘰𝘧𝘧𝘪𝘤𝘪𝘢𝘭 𝘱𝘢𝘨𝘦𝘴 𝘰𝘧 𝘋𝘛𝘐 𝘙𝘦𝘨𝘪𝘰𝘯 2 𝘢𝘯𝘥 𝘰𝘶𝘳 𝘱𝘳𝘰𝘷𝘪𝘯𝘤𝘪𝘢𝘭 𝘰𝘧𝘧𝘪𝘤𝘦𝘴 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘭𝘢𝘵𝘦𝘴𝘵 𝘶𝘱𝘥𝘢𝘵𝘦𝘴, 𝘢𝘯𝘯𝘰𝘶𝘯𝘤𝘦𝘮𝘦𝘯𝘵𝘴, 𝘢𝘯𝘥 𝘦𝘷𝘦𝘯𝘵 𝘩𝘪𝘨𝘩𝘭𝘪𝘨𝘩𝘵𝘴.

Come and be part of the celebration of vibrant hands and lasting heritage. See you there!

08/07/2026

PNP, FDA CRACK DOWN ON SALE OF UNREGISTERED CONSUMER PRODUCTS IN ISABELA; CHINESE NATIONAL ARRESTED

The Philippine National Police (PNP), under the leadership of Chief, PNP, Police General Jose Melencio C. Nartatez Jr., arrested a Chinese national for selling unregistered consumer products during a joint operation with the Food and Drug Administration (FDA) on July 1, 2026, in Barangay District 1, Cauayan City, Isabela, leading to the confiscation of 937 pieces of assorted aerosol insecticides, mosquito coils, and other consumer products with a total estimated value of ₱100,972.00.

The operation was carried out by the Criminal Investigation and Detection Group (CIDG) Isabela Provincial Field Unit, together with representatives of the Food and Drug Administration (FDA), and in coordination with territorial police units.

Arrested was alias “Jin,” a Chinese national, female, and businesswoman-owner of the establishment, who was allegedly caught selling aerosol insecticides and other consumer products without the required Certificate of Product Registration (CPR) issued by the FDA, in violation of Republic Act No. 9711, or the Food and Drug Administration Act of 2009.

Authorities said the confiscated items consisted of assorted aerosol insecticides, mosquito coils, and other consumer products that were not registered with the FDA. Under Republic Act No. 9711, the manufacture, importation, sale, offering for sale, distribution, and transfer of health and consumer products require a valid Certificate of Product Registration to ensure compliance with government standards on safety, quality, and efficacy. The sale and distribution of unregistered products circumvent regulatory safeguards and expose consumers to potential health and safety risks.

This accomplishment reflects the PNP Focused Agenda—a strategic framework for organizational transformation designed to make police service more responsive, accountable, and mission-driven. The operation advances the key priority on Enhanced Managing Police Operations by strengthening the enforcement of regulatory laws that protect public health, uphold consumer safety, and hold violators accountable.

Police General Jose Melencio C. Nartatez Jr. underscored the PNP’s commitment to supporting government efforts against the proliferation of unregistered consumer products that may endanger the public.

“The PNP remains committed to enforcing laws that protect consumers and ensure that products offered in the market comply with government regulations. Those who disregard these standards will face the full force of the law,” he said.

“Hindi natin hahayaan na kumalat ang mga produktong walang sapat na pagsusuri at maaaring magdulot ng panganib sa publiko. Patuloy nating pananagutin ang sinumang lalabag sa batas,” the PNP Chief added.

As the PNP strengthens its campaign against unlawful trade practices and violations of consumer protection laws under the directive of President Ferdinand R. Marcos Jr., the PNP assures the public of “Bagong PNP para sa Bagong Pilipinas: Serbisyong mabilis, tapat, at nararamdaman.”

(PNP-PIO)

07/07/2026

Licensing Seminar for Drug Establishments (LS-D)

A licensing seminar for the FDA Center for Drug Regulation and Research (CDRR) stakeholders which aims to provide information on the rules and regulations prescribing the requirements and procedures on the application for License to Operate (LTO) for drug establishments. The discussion will also include current schedule of fees and charges and processing time.

Join our webinar on 28 August 2026 from 8:00 am to 12:00 nn via Google Meet
Registration fee: Php 500.00
Register through this link: bit.ly/4p6zsgO

Maximum of 1000 participants
First-come-first-served basis

All successful registrants/applicants shall wait for the confirmation email from the FDA Academy for the issuance of Course Assessment Slip (CAS) and payment instruction pursuant to FDA Circular 2023-010.

Payments made without the corresponding CAS from the FDA Academy shall be forfeited.

26/06/2026